- Home LCSB
- News & Events
- Vision & Mission
- Research
- Parkinson's disease map
- Bioinformatics Core
- Biomedical Data Science
- Computational Biology
- Developmental and Cellular Biology
- Digital Medicine
- Environmental Cheminformatics
- Enzymology & Metabolism
- Gene Expression & Metabolism
- Immunology & Genetics
- Integrative Cell Signalling
- Interventional Neuroscience
- Medical Translational Research
- Molecular & Functional Neurobiology
- Neuroinflammation
- Neuropathology
- Systems Control
- Systems Ecology
- Translational Neuroscience
- Animal Research
- Research Support Groups
- Services
- Doctoral Training Unit
- Scienteens Lab
- People
- Publications
- Support the LCSB
- Open Positions
- Contact
Molecular & Functional Neurobiology Group
The Molecular & Functional Neurobiology group at the LCSB First row (from left to right): Semra Smajic, Dr. Sylvie Delcambre, Jenny Ghelfi, Dr. Dajana Grossmann Second row (from left to right): Kobi Wasner, Katja Badanjak, Nassima Ouzren, Dr. Anne Grünewald, Patrycja Mulica, Dr. Sandro Pereir About the Molecular & Functional Neurobiology GroupThe Molecular & Functional Neurobiology Group employs molecular, ‘omics’ and single-cell approaches to decipher the genetic and non-genetic origins of Parkinson’s disease (PD). We explore the role of the mitochondrial genome in the pathogenesis of idiopathic PD (IPD) using post-mortem and iPSC-derived tissues. We aim to identify novel cellular pathways, which may be targets for therapeutic intervention in the future. With regard to genetic PD, we are particularly interested in reduced penetrance, i.e. the phenomenon that despite the presence of a disease-causing variant, some individuals will never develop any signs of PD. Here, we aim to uncover disease progression markers as well as molecular mechanisms that can be modulated by drugs to delay the onset of PD.
The Molecular and Functional Neurobiology group was established under the auspices of the Luxembourg National Research Fund's ATTRACT Programme.
|